 |
 |

At Polio's End Game, Strategies Differ
Brian Vastag
JAMA. 2001;286:2797-2799.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
BaltimoreAs a young student, Walter Orenstein, MD, head of the US National Immunization Program, idolized Jonas Salk, MD. Orenstein's favorite story about the discoverer of one polio vaccine takes place at a meeting where the well-known friction between Salk (who died in 1995) and the other polio vaccine discoverer, Albert Sabin, MD (who died in 1993), came to a head. As participants debated the merits of the Salk and Sabin vaccines, Salk stood up and said, "There is something we can agree on. The world needs just one vaccine."
The world eventually got Sabin's, to the tune of hundreds of millions of doses. Since the 1988 launch of a worldwide eradication campaign, the Sabin oral polio vaccine (OPV) has cut the number of new cases by 99%, saving some 3 million children from paralysis. But for Orenstein, who was here to deliver the University of Maryland's annual . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Non-parenteral vaccines
Li Wan Po
BMJ 2004;329:62-63.
FULL TEXT
|